Paraoxonase 1 Mutations in a Turkish Population
- 15 June 1999
- journal article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 157 (3) , 174-177
- https://doi.org/10.1006/taap.1999.8690
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- High frequency of CYP1A1 mutations in a Turkish populationArchives of Toxicology, 1998
- Effect of the molecular polymorphisms of human paraoxonase (PON1) on the rate of hydrolysis of paraoxonBritish Journal of Pharmacology, 1997
- Arylamine N-acetyltransferase (NAT2) genotypes in a Turkish populationPharmacogenetics, 1997
- Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes.Journal of Clinical Investigation, 1997
- The Gln/Arg polymorphism of human paraoxonase (PON 192) is not related to myocardial infarction in the ECTIM StudyAtherosclerosis, 1996
- The Gln-Arg191 polymorphism of the human paraoxonase gene (HUMPONA) is not associated with the risk of coronary artery disease in Finns.Journal of Clinical Investigation, 1996
- Determination and allelic allocation of seven nucleotide transitions within the arylamine N-acetyltransferase gene in the Polish populationClinical Pharmacology & Therapeutics, 1996
- The molecular basis of the human serum paraoxonase activity polymorphismNature Genetics, 1993
- Analysis of the serum paraoxonase/arylesterase polymorphism in a Turkish populationPharmacogenetics, 1991
- Absence of “A”-esterase activity in the serum of a patient with tangier diseaseClinical Biochemistry, 1989